家家悦(603708.SH)已成為山東華潤萬家生活超市有限公司的唯一股東
格隆匯11月22日丨家家悦(603708.SH)公佈,公司第三屆董事會第七次會議審議通過《關於擬參與競拍山東華潤萬家生活超市有限公司100%股權的議案》,同意公司參與競拍山東華潤萬家生活超市有限公司100%股權。
根據上海聯合產權交易所通知,確認公司為該股權轉讓項目的受讓方。2019年9月20日,公司與天津華潤萬家生活超市有限公司簽訂《產權交易合同》。
2019年11月21日,山東華潤萬家生活超市有限公司完成工商變更登記手續,公司已成為山東華潤萬家生活超市有限公司的唯一股東,並取得了由濟南市市中區行政審批服務局頒發的《營業執照》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.